Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome
- 1 September 2006
- journal article
- editorial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 116 (9), 2330-2332
- https://doi.org/10.1172/JCI29807
Abstract
In this issue of the JCI, Stasch and colleagues suggest that a novel drug, BAY 58-2667, potently activates a pool of oxidized and heme-free soluble guanylyl cyclase (sGC; see the related article beginning on page 2552). The increased vasodilatory potency of BAY 58-2667 the authors found in a number of animal models of endothelial dysfunction and in human blood vessels from patients with diabetes suggests that there exists a subphenotype of endothelial dysfunction characterized by receptor-level NO resistance. Diseases associated with NO resistance would appear to be ideally suited for therapies directed at restoring redox homeostasis, sGC activity, and NO sensitivity.This publication has 22 references indexed in Scilit:
- Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vesselsJCI Insight, 2006
- eNOS Gene Therapy Exacerbates Hepatic Ischemia-Reperfusion Injury in DiabetesCirculation Research, 2006
- Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobinJCI Insight, 2005
- Nitrate tolerance and the links with endothelial dysfunction and oxidative stressBritish Journal of Clinical Pharmacology, 2003
- Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood VesselsCirculation, 2003
- Hemoglobin and the Paracrine and Endocrine Functions of Nitric OxideThe New England Journal of Medicine, 2003
- Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.JCI Insight, 1995
- Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circulation Research, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980